Literature DB >> 2573419

Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.

J B Park1, J S Rhim, S C Park, S W Kimm, M H Kraus.   

Abstract

Four of 51 primary gastric carcinomas exhibited amplification of the erbB-2 protooncogene ranging from 2- to 8-fold. In three cases gene amplification affected erbB-2 alleles of normal gene structure as determined by Southern blot analysis. In addition, one tumor displayed gene amplification of an apparently rearranged erbB-2 allele. Analysis of the rearranged allele revealed a structural alteration consistent with an internal deletion of approximately 2 kilobase pairs within the erbB-2 gene. Quantitation of erbB-2 mRNA in these tumors demonstrated that gene amplification coincided with overexpression of erbB-2 mRNA ranging from 8- to 32-fold above levels observed in stomach tumors without gene amplification. Furthermore, in one of the tumors with amplified normal size erbB-2 restriction fragments, elevated erbB-2 mRNA levels consisted of the normal size 5-kilobase transcript. Thus, overexpression of normal size erbB-2 mRNA accompanies gene amplification in primary stomach tumors. In addition, evidence for erbB-2 gene rearrangement suggests a role for such alteration in the development of certain gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573419

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  c-erbB-2 oncogene product expression and prognosis in gastric carcinoma.

Authors:  D A Hilton; K P West
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

Review 2.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

3.  Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.

Authors:  K Sasaki; Y Tomita; M Azuma; S Shida; B Simizu
Journal:  Gastroenterol Jpn       Date:  1992-04

4.  Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.

Authors:  Yao Zheng; Lin Wang; Jian-Ping Zhang; Jing-Yan Yang; Zhu-Mei Zhao; Xiao-Ying Zhang
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

5.  Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.

Authors:  G D Lewis; I Figari; B Fendly; W L Wong; P Carter; C Gorman; H M Shepard
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

6.  Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.

Authors:  H Schimmelpenning; E T Eriksson; U G Falkmer; E Azavedo; G Svane; G U Auer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 7.  Helicobacter pylori infection and molecular changes in gastric carcinogenesis.

Authors:  Matthias P A Ebert; Laszlo Schandl; Peter Malfertheiner
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas.

Authors:  Amanda K Arrington; Peter S Dahlberg; Julia Davydova; Selwyn M Vickers; Masato Yamamoto
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

9.  Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor.

Authors:  L Bangalore; A J Tanner; A P Laudano; D F Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 10.  Nature meets nurture: molecular genetics of gastric cancer.

Authors:  Anya N Milne; F Carneiro; C O'Morain; G J A Offerhaus
Journal:  Hum Genet       Date:  2009-08-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.